Sun, Sep 21, 2014, 7:20 AM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

ImmunoGen, Inc. Message Board

  • bioimmunomabman bioimmunomabman Aug 27, 2013 9:55 PM Flag

    Looks like Cramer is switching to SGEN

    He's calling SGEN a prime takeout candidate, no mention of IMGN. Junius has lost credibility with one of IMGN's few remaining supporters. Was today's executive change just the BOD's first step? I highly doubt Junius asked Perry to leave. Maybe IMGN's large owners have started to take action to push for positive change. Still curious to know if 901 is a real drug, or a place holder.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • With all the management issues going on now, the probability of a IMGN takeover is much higher than
      SGEN.
      I like both companies!

      Sentiment: Strong Buy

    • I'm thinking Pfizer would be a good one to buy-out IMGN. They didn't do so well with their own ADC, and IMGN's technology is now proven. PFE has plenty of money, needs growth, and they have fine leadership. Plus IMGN is cheap now, especially compared to SGEN. It got left out of the biotech run-up, even as it won its landmark FDA approval. Nobody is buying the biotechs for their management. Funny thought, that. No offense, Dan. Please enjoy your retirement.

      Sentiment: Buy

 
IMGN
11.35+0.01(+0.09%)Sep 19 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.